- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/57 - IFN-gamma
Patent holdings for IPC class C07K 14/57
Total number of patents in this class: 210
10-year publication summary
|
12
|
13
|
11
|
19
|
20
|
21
|
15
|
23
|
18
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Innovative Cellular Therapeutics Holdings, Ltd. | 76 |
8 |
| The Regents of the University of California | 19961 |
7 |
| Rutgers, The State University of New Jersey | 1893 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
5 |
| The Brigham and Women's Hospital, Inc. | 2195 |
5 |
| CytomX Therapeutics, Inc. | 222 |
5 |
| Werewolf Therapeutics, Inc. | 54 |
5 |
| Immunowake Inc. | 12 |
5 |
| Bolder Biotechnology, Inc. | 15 |
4 |
| Universiteit Gent | 1335 |
4 |
| Vib VZW | 881 |
4 |
| Innovative Cellular Therapeutics Inc. | 56 |
4 |
| Orionis Biosciences BV | 83 |
4 |
| Massachusetts Institute of Technology | 10062 |
3 |
| Agency for Science, Technology and Research | 3628 |
3 |
| Lonza Sales AG | 119 |
3 |
| Tilt Biotherapeutics Oy | 27 |
3 |
| The University of Western Australia | 198 |
3 |
| Wayne State University | 685 |
3 |
| Marengo Therapeutics, Inc. | 80 |
3 |
| Other owners | 122 |